SK16052001A3 - Aromatické amidy - Google Patents

Aromatické amidy Download PDF

Info

Publication number
SK16052001A3
SK16052001A3 SK1605-2001A SK16052001A SK16052001A3 SK 16052001 A3 SK16052001 A3 SK 16052001A3 SK 16052001 A SK16052001 A SK 16052001A SK 16052001 A3 SK16052001 A3 SK 16052001A3
Authority
SK
Slovakia
Prior art keywords
group
propionyl
amino
diethylaminoethyl
radical
Prior art date
Application number
SK1605-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Justin Stephen Bryans
John Calm O'toole
David Christopher Horwell
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of SK16052001A3 publication Critical patent/SK16052001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • C07C247/16Compounds containing azido groups with azido groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/46Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1605-2001A 1999-05-10 2000-05-10 Aromatické amidy SK16052001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13335999P 1999-05-10 1999-05-10
PCT/GB2000/001788 WO2000068184A1 (en) 1999-05-10 2000-05-10 Aromatic amides

Publications (1)

Publication Number Publication Date
SK16052001A3 true SK16052001A3 (sk) 2002-11-06

Family

ID=22458233

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1605-2001A SK16052001A3 (sk) 1999-05-10 2000-05-10 Aromatické amidy

Country Status (28)

Country Link
US (1) US6846953B1 (pt)
EP (1) EP1178953B1 (pt)
JP (1) JP2002544186A (pt)
KR (1) KR20010111594A (pt)
CN (1) CN1352631A (pt)
AP (1) AP2001002321A0 (pt)
AT (1) ATE255559T1 (pt)
AU (1) AU4594900A (pt)
BG (1) BG106072A (pt)
BR (1) BR0010465A (pt)
CA (1) CA2373173A1 (pt)
CR (1) CR6500A (pt)
CZ (1) CZ20013924A3 (pt)
DE (1) DE60006954T2 (pt)
DK (1) DK1178953T3 (pt)
EA (1) EA200101058A1 (pt)
ES (1) ES2208324T3 (pt)
HU (1) HUP0201069A3 (pt)
IL (1) IL146340A0 (pt)
IS (1) IS6136A (pt)
MA (1) MA26789A1 (pt)
NO (1) NO20015412L (pt)
OA (1) OA11941A (pt)
PL (1) PL354356A1 (pt)
PT (1) PT1178953E (pt)
SK (1) SK16052001A3 (pt)
TR (1) TR200103245T2 (pt)
WO (1) WO2000068184A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006043171A2 (en) * 2004-10-23 2006-04-27 Warner-Lambert Company Llc Methods of using alpha2delta-1 selective compounds
WO2011026107A1 (en) 2009-08-31 2011-03-03 University Of Notre Dame Du Lac Phthalanilate compounds and methods of use

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB855770A (en) 1956-12-27 1960-12-07 American Cyanamid Co N-substituted anilides and their preparation
US3101339A (en) * 1958-10-30 1963-08-20 Boehringer Sohn Ingelheim Quaternary salts of normorphine and its acylated derivatives
US3016382A (en) 1958-12-15 1962-01-09 American Cyanamid Co N-substituted anilides and method of preparing the same
DE1232147B (de) 1961-04-13 1967-01-12 Bayer Ag Verfahren zur Herstellung von acylierten N-(Alkylaminoalkyl)-aminopyridinen
GB1232787A (pt) 1967-08-08 1971-05-19
FR2073286A1 (en) 1969-12-23 1971-10-01 Robert Et Carriere Labo Substd anilines - with antirheumatic analgesic and antiinflammatory activity
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
US4180522A (en) 1976-12-02 1979-12-25 The Upjohn Company N-(2-Dimethylaminoalkyl)-3',4'-dichloroanilides
US4186208A (en) 1976-12-02 1980-01-29 The Upjohn Company Anti-depressant N-(3,4-dichlorophenyl)-N-dimethylaminoalkylene amides
JPS5520471A (en) 1978-08-01 1980-02-13 Kyowa Hakko Kogyo Co Ltd Hydrogen peroxide quantifying method
US4286106A (en) 1978-08-16 1981-08-25 The Upjohn Company N-[ω-(Dimethylamino)alkyl]-3',4'-dichloropropionanilides
US4241072A (en) 1979-01-18 1980-12-23 Merck & Co., Inc. Substituted ureas and processes for their preparation
US4293703A (en) 1979-01-18 1981-10-06 Merck & Co., Inc. Imidazole or imidazoline substituted ureas
ATE11770T1 (de) * 1981-12-14 1985-02-15 Sandoz-Erfindungen Verwaltungsgesellschaft M.B.H. N,n,disubstituierte alkenamide und phenylaldenamide, verfahren zu deren herstellung und deren verwendung als pharmazeutika.
DE3406329A1 (de) 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
US5654301A (en) * 1985-02-15 1997-08-05 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US4952584A (en) 1986-01-11 1990-08-28 Beecham Group P.L.C. 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
CA1292226C (en) 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
FR2618149B1 (fr) 1987-07-16 1989-09-22 Synthelabo Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique
US5474994A (en) 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
US5605896A (en) 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
IT1254469B (it) 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US5372932A (en) 1992-12-22 1994-12-13 Eastman Kodak Company Analytical element and method for the determination of a specific binding ligand using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5453533A (en) 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5880158A (en) 1996-09-27 1999-03-09 Research Corporation Tech., Inc. Propionamide anticonvulsants
GB9707830D0 (en) * 1997-04-18 1997-06-04 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
CA2373173A1 (en) 2000-11-16
ATE255559T1 (de) 2003-12-15
WO2000068184A1 (en) 2000-11-16
US6846953B1 (en) 2005-01-25
HUP0201069A2 (hu) 2002-07-29
MA26789A1 (fr) 2004-12-20
CN1352631A (zh) 2002-06-05
BR0010465A (pt) 2002-02-13
CR6500A (es) 2004-03-08
NO20015412D0 (no) 2001-11-06
EP1178953B1 (en) 2003-12-03
NO20015412L (no) 2002-01-09
DK1178953T3 (da) 2004-03-15
IS6136A (is) 2001-10-30
AU4594900A (en) 2000-11-21
AP2001002321A0 (en) 2001-12-31
EP1178953A1 (en) 2002-02-13
IL146340A0 (en) 2002-07-25
OA11941A (en) 2006-04-12
KR20010111594A (ko) 2001-12-19
DE60006954D1 (de) 2004-01-15
JP2002544186A (ja) 2002-12-24
EA200101058A1 (ru) 2002-06-27
BG106072A (en) 2002-05-31
PT1178953E (pt) 2004-04-30
PL354356A1 (en) 2004-01-12
DE60006954T2 (de) 2004-10-21
ES2208324T3 (es) 2004-06-16
HUP0201069A3 (en) 2002-11-28
TR200103245T2 (tr) 2002-04-22
CZ20013924A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
KR100412747B1 (ko) 2-(4-치환된)-벤질아미노-2-메틸-프로판아미드유도체,이의제조방법및이를포함하는약제학적조성물
CH643817A5 (de) Verfahren zur herstellung von neuen benzamid-derivaten.
JPH0649011A (ja) 新規ナフチルアルキルアミン、その製造法及びそれを含む医薬組成物
WO1995029891A1 (fr) Derive de n-(3-pyrrolidinyl)benzamide
EP0248824B1 (en) Use of cis-n-(2 aminocycloaliphatic) benzene acetamide and benzamide for the manufacture of anticonvulsants
Barlow et al. Structure activity studies related to 2-(3, 4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl] acetamides: a novel series of potent and selective. kappa.-opioid agonists
US4328155A (en) Meta-sulfonamido-benzamides
JPH03204866A (ja) オキシトシン拮抗薬としての3―置換―1,4―ベンゾジアゼピン類
CZ99091A3 (en) Stereochemically pure derivative of 2-hydroxycyclopentylamide of ergoline, its use, process of its preparation and pharmaceutical composition containing thereof
EA001399B1 (ru) Ингибиторы пролилэндопептидазы
US5449692A (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
SK16052001A3 (sk) Aromatické amidy
JP4852537B2 (ja) 免疫抑制へテロ環化合物
KR100450313B1 (ko) 이소인돌로인돌론 화합물, 이들의 제조 방법, 및 이들을함유하는 약제 조성물
DE69717841T2 (de) Substituierte n-arylmethylamino-cyclobuten-3,4-dion-derivate
MXPA01011527A (en) Aromatic amides
CA2551128A1 (en) Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifiying and obtaining the polymorphs thereof
SK61597A3 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
EP1777219A1 (en) 1,2-Substituted naphthalene derivatives with antiglutamatergic properties and uses thereof
EA008250B1 (ru) Новые соединения фенилнафталина, способ их получения и фармацевтические композиции, которые их содержат